Criteria for who should get heart surgery and when are based primarily on research in men, but two studies suggest this leads ...

Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal ...

EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.

In January, Mount Carmel East hospital opened a new hybrid cardiovascular operating room as part of their ongoing commitment ...

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

Edwards pushes CMS to expand Medicare TAVR coverage to asymptomatic patients, sparking controversy among physicians over ...

Edwards Lifesciences Corporation (NYSE:EW) is a medical technology company that develops and provides patient-focused innovations for heart conditions, specializing in structural heart disease ...

Anteris Technologies says Medtronic will make a strategic investment of up to $90 million in the transcatheter heart valve developer.

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.

Intuitive Surgical ISRG recently announced that the FDA has granted 510(k) clearance for the da Vinci 5 system to be used in ...

Mount Carmel Health System has announced the opening of a new state-of-the-art hybrid cardiovascular operating room at Mount ...

NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...